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Abstract
Background: Cricoid pressure is considered to be the gold standard means of preventing aspiration of gastric
content during Rapid Sequence Intubation (RSI). Its effectiveness has only been demonstrated in cadaveric studies
and case reports. No randomised controlled trials comparing the incidence of gastric aspiration following emergent
RSI, with or without cricoid pressure, have been performed. If improperly applied, cricoid pressure increases risk to
the patient. The clinical significance of aspiration in the emergency department is unknown. This randomised
controlled trial aims to; 1. Compare the application of the ‘ideal” amount of force (30 - 40 newtons) to standard,
unmeasured cricoid pressure and 2. Determine the incidence of clinically defined aspiration syndromes following
RSI using a fibrinogen degradation assay previously described.
Methods/design: 212 patients requiring emergency intubation will be randomly allocated to either control
(unmeasured cricoid pressure) or intervention groups (30 - 40 newtons cricoid pressure). The primary outcome is
the rate of aspiration of gastric contents (determined by pepsin detection in the oropharyngeal/tracheal aspirates
or treatment for aspiration pneumonitis up to 28 days post-intubation). Secondary outcomes are; correlation
between aspiration and lowest pre-intubation Glasgow Coma Score, the relationship between detection of pepsin
in trachea and development of aspiration syndromes, complications associated with intubation and grade of the
view on direct largyngoscopy.
Discussion: The benefits and risks of cricoid pressure application will be scrutinised by comparison of the
incidence of aspiration and difficult or failed intubations in each group. The role of cricoid pressure in RSI in the
emergency department and the use of a pepsin detection as a predictor of clinical aspiration will be evaluated.
Trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12611000587909
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Background
Rapid sequence intubation (RSI) is the process by which
anaesthetic and neuromuscular blocking agents are admi-
nistered in rapid succession to facilitate endotracheal intu-
bation [1]. In the emergency department (ED) RSI is
typically performed on acutely ill or injured patients who
are often not fasted, increasing the risk of gastric aspira-
tion during the process. In 1961 Sellick reported using
“occlusion of the upper oesophagus by backwards pressure
on the cricoid ring against the bodies of the cervical ver-
tebrae to prevent gastric contents from reaching the phar-
ynx” during induction of anaesthesia in patients at high
risk of aspiration [2]. Cricoid pressure (CP) was subse-
quently adopted as an integral component of RSI in EDs
despite inadequate scientific evaluation of its risks and
benefits; its effectiveness has subsequently only been
demonstrated in cadavers [3-6]. No randomised controlled
trials have shown any benefit of its use during RSI.
Furthermore the application of CP may be associated with
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ment [7,8]; prolonging intubation time by obscuring laryn-
geal view [9,10]; inducing nausea/vomiting [10] and
oesophageal rupture with excessive force [11]. Paradoxi-
cally, CP may indeed promote aspiration by relaxing the
lower part of the oesophagus [12]. Some case reports note
that tracheal intubation was impeded by CP [13] and
regurgitation occurred despite application of CP [14,15],
possibly due to its improper application.
Ostensibly a simple procedure, CP is in practice a com-
plex manoeuvre which is difficult to perform optimally
[12]. The amount of force used by the cricoid operator is
a crucial factor in proper application of CP. A force in
the range of 30 - 40 Newtons (N) applied to the cricoid
ring is generally accepted as sufficient to occlude the
oesophagus [5,12,16-18], preventing regurgitation of gas-
tric contents. Studies have revealed that the knowledge of
cricoid force theory and concept of the forces required is
poor amongst both anaesthetic and ED staff [19-31].
Considerable ranges in the amount of force used by staff
when applying force to cricoid models have been
described [29,31,32]. Furthermore, when ED staff were
asked to apply “ideal” CP to a human larynx model, only
25% of the group reached the target range, while 47%
applied insufficient and 28% applied excessive force [29].
At forces greater than 44 N the patient is considered to
be at risk of oesophageal rupture [5,10]. Training staff
how to gauge the correct amount of force to use is effec-
tive in the short term only, however, in practice training
is rarely undertaken [23,25,26,31,33,34]. In addition, the
effect of fatigue on the ability of the cricoid operator to
maintain CP within the target range for the duration of
prolonged intubations has been questioned [35]. The use
of floor scales to provide a means of gauging the amount
of force applied to a cricoid model has been demon-
strated [25], however its use in real-time measurement
during RSI has not been reported.
Aspiration of gastric or oropharyngeal contents into
the larynx and lower respiratory tract may lead to various
pulmonary syndromes, most notably pneumonia and
pneumonitis. The true incidence and clinical significance
of aspiration during RSI is difficult to establish due to the
heterogeneous nature of pathologic processes of critically
ill patients requiring an emergency airway. Compounding
this is the fact that many patients aspirate prior to intu-
bation or arrival at ED and that repeated attempts at
intubation increased the incidence of aspiration (Mort et
al. 2004). Mort reported that the rate of aspiration
increased from 1.9% with one attempt at intubation to
22% with three or more attempts [36]. Given these lim-
itations, the incidence of aspiration appears to lie any-
where between 0.8% [36] and 22% [37]. There is
currently no widely available test to determine whether
pulmonary aspiration has occurred during RSI. Pepsin
detection has been described as a potential aspiration
biomarker [38] since it is uniquely secreted in stomach.
Ufberg has developed and validated a specific and sensi-
tive pepsin assay as a marker of aspiration [39]. Using the
assay he found pepsin in the lungs in 50% of patients
intubated in the pre-hospital setting, and 22% of patients
undergoing RSI in the ED [37], however there was no
longitudinal follow-up to see whether the presence of
pepsin in the lungs was linked to subsequent develop-
ment of aspiration syndromes. It was also not possible to
determine if aspiration occurred prior to or at the time of
intubation.
The value of CP in RSI is under increasing scrutiny
[40,41]. Since its introduction in the 1960s anaesthesia
practices and airway management techniques have
improved leading some to wonder what contribution CP
now makes towards reduced aspiration rates [40]. Criti-
cally ill patients presenting to the ED are also likely to
have aspirated prior to intubation [40], therefore negat-
ing necessity for CP in the ED.
Emergency physicians today need evidence to support
t h eu s eo fC Pi nt h eE D .T h ec u r r e n ts t u d ya i m st o
address these issues, being designed to evaluate the
effectiveness, safety and need for CP during RSI in EDs.
Study design
This is a prospective randomised blinded controlled
study of RSI and CP application within the ED. Due to
ethical considerations, a control group without CP
applied cannot be included in any study. Instead, this
study will exploit the fact that the target range CP of 30 -
40 newtons (N) was applied only 25% of the time by ED
staff when tested on a model larynx [29]. The incidence
of aspiration (determined by pepsin detection in the tra-
chea) in two groups of patients will be compared; those
with conventional CP (and hence about a 25% chance of
target range CP), and those with exact sustained target
range CP (using weighing scales for direct biofeedback).
Longitudinal follow-up of participants will be performed
to determine to what degree detection of pepsin in the
trachea correlates with the development of clinical
aspiration syndromes. In addition the incidence of aspira-
tion as a result of pre-hospital intubation (determined by
pepsin detection in the trachea) will be determined.
Study objectives
Primary aims
￿ Test the hypothesis that the use of CP during RSI
in the ED does not prevent aspiration.
￿ Investigate the effect of CP on RSI and associated
incidence of difficulty or failed intubation.
￿ Determine the incidence of pre-hospital aspiration.
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￿ Determine whether a relationship exists between
the incidence of aspiration and pre-intubation Glas-
gow coma score (GCS).
￿ Determine any correlation between pepsin detec-
tion in aspirates and development of clinical aspira-
tion syndromes.
Setting
Three hospitals will participate in the trial: Tamworth
Rural Referral Hospital (Hunter New England Local
Health District), and Port Macquarie and Coffs Harbour
Base Hospitals (Mid North Coast Local Health District).
Participants
Adult patients (> 18 years) undergoing RSI in the ED
will be invited to participate in the study. Patients will
be randomised to receive either standard CP (Control
arm) or sustained “ideal” CP (Intervention arm). Patients
will be excluded from the trial if cardiopulmonary resus-
citation (CPR) is in progress upon arrival at the ED.
Consent
Consent will be sought from the patient (or their Next of
Kin) to participate in the trial, for testing the endotracheal
and oropharyngeal aspirates for pepsin and for the 28 day
follow-up. The right to refuse is clearly stated on the con-
sent form. Patient consent is sought by the CP operator.
In instances where a relative consents for the trial, partici-
pant consent is sought as soon as practicable after they
have been successfully intubated and stabilised.
The study protocol has been approved by both the
Hunter New England Human Research Ethics and the
North Coast Area Health Service Human Research
Ethics Committees.
Randomisation
Patients will be randomised to the treatment groups by a
directive included in the enrollment pack which is not
apparent until the pack is opened to ensure all staff mem-
bers are blinded to the participant’s group allocation.
Interventions
Intervention arm
The cricoid operator will stand on a set of scales with a
visible display providing direct feedback of the force
a p p l i e dt ot h ec r i c o i dw h i le performing CP. When
required, the operator will apply 30 - 40 N force (equat-
ing to a weight displacement of 3.060 - 4.075 kg [29]) to
the cricoid during RSI unless otherwise instructed by the
intubation operator. Force will be applied until the endo-
tracheal tube (ETT) placement is confirmed by end tidal
CO2 and the ETT cuff is inflated.
Control arm
The cricoid operator will stand on a set of scales while
performing CP. The scale display will be covered to blind
the operator to the amount of force they are using. When
required, the cricoid operator will apply what they con-
sider to be 30 - 40 N force to the cricoid during RSI unless
otherwise instructed by the intubation operator. Force will
be applied until the ETT placement is confirmed by end
tidal CO2 and the ETT cuff is inflated.
Outcome measures
Primary outcome measures
￿ Rate of aspiration (pepsin detection in tracheal
aspirate)
￿ Treatment for aspiration pneumonitis
Secondary outcome measures
￿ Grade of laryngeal view
￿ Detection of pepsin in oropharyngeal aspirates
￿ Procedural complications associated with intubation
￿ Immediate complications (associated with RSI)
within 30 minutes of intubation
￿ Lowest pre-intubation GCS
￿ Survival to 28 days/hospital discharge
Methods
Cricoid pressure measurement
A platform scale with pole-mounted liquid crystal display
LCD (150 kg capacity) set to record in 0.01 kg increments
is used to measure cricoid pressure (Figure 1. Model
PT270, PT Global Pty Ltd., NSW, Australia). The scale is
mounted on a hand trolley with a custom made extended
toe plate (designed to support the base plate of the scale
without interfering with its levelling feet) allowing it to be
easily manoeuvred into position next to the resus bed
when required. Once in position and turned on, the cri-
coid operator stands on the scale and select the tare
option to display their body weight as zero. Direct feed-
back of the force applied to the cricoid is available via the
displayed weight reduction (a reading of -1 kg equates to
approximately 10 N force). The cricoid operator maintains
contact only with the scale baseplate and the patient’s cri-
coid cartilage during the procedure to ensure the weight
displayed accurately reflects the amount of their body
weight transferred through the patient’s cricoid.
Weight data is collected from the time the cricoid
operator stands on the scales via a serial data recorder
(model SDX, Photologic Ltd., Ottawa, Canada) onto a 2
gigabyte Secure Digital (SD) card. The scales transmit at
a rate of 60 data points per second.
Aspirate collection
Following successfully placement of the ETT, aspirates
from the oropharynx and the trachea will be collected
using 12 gauge suction catheters (Unomedical, Sydney,
Australia) connected to 40 ml specimen traps (Kendall
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normal saline will be instilled into the ETT, the patient
ventilated for 5 breaths and the collection repeated.
Using a fresh transfer pipette, each aspirate will be trans-
ferred to a specimen tube containing 0.5 ml 0.1 M citric
acid (pH 2.5) to maintain pepsin stability [42]. The tubes
will then be labeled with a unique fibrinogen Plate Num-
ber which becomes the means through which all data for
the research will be tracked.
Pepsin assay
Ufberg’s pepsin plate assay is reliant upon test samples
containing enzymatically active pepsin. Pepsin activity is
highly sensitive to pH with maximum activity between
pH 1.5-2.5 and irreversible inactivation occurring above
pH 7.5 [43]. Pepsin stored in gastric juice samples at 4°
C remains active for up to 3 days (evaluated up to pH
6)[44]. The pH of saliva sampled from patients following
episodes of gastric regurgitation has been reported to
range from 7-8 [45]. Therefore citric acid (pH 2.5) will
be added to aspirates to ensure pepsin activity is main-
tained prior to testing.
The laboratory will perform the qualitative pepsin plate
assay based on fibrinogen digestion according to the
method of Ufberg et al. [39]. Briefly, 1.25% agarose plates
are prepared with bovine fibrinogen (in normal saline)
added to a final concentration of 1 mg/ml. Four wells are
punched into the agarose, each capable of holding 7 μlo f
test sample. Porcine pepsin (positive control) and normal
saline (negative control) are included on each plate along
with a sample of each aspirate from one patient. The
plates are left in a humid chamber for up to 24 hours
when they are read by visual inspection. A positive result
is recorded if there is visible clearing zone around a well.
No clearing zone visible after 24 hours is recorded as a
negative result. The plate is checked progressively after
sample addition initially every 2 hours, in this way a posi-
tive tracheal result can be communicated to the clinician.
Data collection
After the intubation is complete the personnel involved
complete a data sheet included in the trial enrollment
pack. Data recorded includes patient demographics, pro-
cedural details, procedural and post-intubation compli-
cations encountered.
Patient demographic details;a g e ,d a t e&t i m eo f
intubation and medical record number (for 28 day
follow-up).
Procedural details; location of intubation (ED or pre-
hospital), lowest pre-intubation GCS, intubation
drugs used, experience of intubation operator, evi-
dence and nature of macroscopic aspirate seen and
grade of laryngoscopic view obtained.
Procedural complications; 3 or more attempts to
place the ETT in the trachea, > 10 minutes using
conventional laryngoscopy, required change of
operator, termination of the attempt at RSI, use of
laryngeal mask or surgical airway.
Post-intubation complications encountered within 30
minutes of RSI; severe hypotension (Systolic blood
pressure < 60 mmHg), severe hypoxaemia (SaO2 <
70%), death and cardiac arrest.
The data sheet and SD card containing weight data will
be sent to the Trial Coordinator who will enter the data
into a password-protected database. Each episode of RSI
has a unique randomly assigned number within the data-
base (Plate Number). This number will be linked to the
Figure 1 Platform scale with pole mounted display and serial
data logger connected, secured to a hand trolley.
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matically appended to the corresponding patient data set
in the database. The investigators are therefore blinded to
the results coming in from the laboratory.
At 28 days the patient notes will be reviewed. The
acute physiology and chronic health evaluation
(APACHE II) score and diagnostic code will be deter-
mined and any treatment for aspiration as an inpatient
(discharge diagnosis of aspiration pneumonitis/pneumo-
nia or antibiotic therapy explicitly instituted to treat for
aspiration pneumonia) will be noted.
Sample processing
The aspirates are sent directly to the hospital’sp a t h o l -
ogy laboratory for pepsin detection or, if outside pathol-
ogy opening hours, stored at 4°C until the laboratory
opens. Tamworth and Port Macquarie hospitals have
access to a 24 hour pathology laboratory, while Coffs
Harbour hospital’s pathology service operates between
0700-2400 hours. Each laboratory is blinded to the con-
duct of CP during the intubation.
Sample size
In order to adequately power the trial the variation in
the rates of aspiration reported in the literature (0.8% to
22%) must be reconciled. Sellick’s original data indicates
a rate of 11% [2]. Therefore, assuming a rate of 11%
aspiration in the control arm, 0% aspiration in the inter-
vention arm and a power of 90% (alpha error = 0.05),
106 patients must be randomised to each group.
Analysis
Continuous measurements will be expressed with means
and standard deviations. Frequencies will be published
the variables of interest. Two group comparisons will be
undertaken using the Chi-squared test or Fisher’s exact
test where appropriate. Comparisons of means will uti-
lise an independent t test. Ordinal and continuous vari-
ables will be compared using a Mann-Whitney test.
Staff education
All staff assisting with the trial will complete a manda-
tory education DVD to ensure uniformity can be main-
tained across the participating hospitals. The DVD
consists of an explanation of the trial, reviewing the
anatomy of the upper airway, standardising location of
the cricoid ring, deliveryo f3 0-4 0NC Pd u r i n gt h e
intubation, operation of the scales and serial data recor-
der, and data collection.
Discussion
The primary aim of this study is two-fold. Firstly, by
comparing the incidence of aspiration of pepsin in the
intervention and control groups and prospectively
documenting the benefits and adverse events associated
with 30 - 40 N of cricoid force during RSI, it aims to
challenge the notion that CP prevents aspiration. Sec-
ondly, since the presence of pepsin in the oropharynx
will be indicative of aspiration having occurred prior to
intubation by virtue of the injury sustained by the
patient, determining the incidence of pre-intubation
aspiration will allow us to further evaluate the relevance
of CP in the RSI algorithm in ED.
T h es e c o n d a r ya i mo ft h i ss t u d yi sa l s ot w o - f o l d .
Firstly, defining any observed correlation between
aspiration and pre-intubation Glasgow coma score will
provide evidence for indications for the use of CP
dependent upon the level of patient consciousness. Sec-
ondly, a correlation between detection of pepsin in tra-
chea and development of aspiration syndromes will
support the use of Fibrinogen plate assay in a clinical
setting for their early detection and treatment.
It is conceivable that this research could also give rise
to novel therapy. For example, once the incidence of
serious aspiration and a pepsin positive assay is identi-
fied, the plate assay for pepsin could potentially be per-
formed at the bedside, enabling doctors to treat
aspiration pneumonia much earlier. It may also lead to
amendments to the algorithm for RSI if CP is found to
be deleterious.
Trial status
Ongoing.
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